PTGX Overview
Upcoming Projects (PTGX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (PTGX)
-
Analyzing Phase 3 ICONIC Trial Results for Icotrokinra (JNJ-2113) in Moderate-to-Severe Plaque Psoriasis from Protagonist Therapeutics (PTGX)
Ticker: PTGX
Executed On: Dec 05, 2024 at 12:00 PM EST -
A Second Look: Exploring the Future of Polycythemia Vera Treatment: A Deep Dive into Protagonist Therapeutics, Inc.'s Rusfertide (PTG-300) Development.
Ticker: PTGX
Executed On: Mar 12, 2024 at 11:00 AM EDT -
Exploring the Future of Polycythemia Vera Treatment: A Deep Dive into Protagonist Therapeutics, Inc.'s Rusfertide (PTG-300) Development.
Ticker: PTGX
Executed On: Feb 12, 2024 at 11:00 AM EST -
A Second Perspective: Discussing a4b7 integrin blocking in moderate to severe ulcerative colitis: Looking at 1st gen PTG-100 and MORF-057
Tickers: MORF, PTGX, TAK
Executed On: Feb 04, 2022 at 11:00 AM EST -
A discussion around a4b7 integrin blocking in moderate to severe ulcerative colitis: Looking at 1st gen PTG-100 and MORF-057
Tickers: MORF, PTGX, TAK
Executed On: Feb 01, 2022 at 02:00 PM EST
Expired Projects (PTGX)
Upcoming & Overdue Catalysts (PTGX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (PTGX)
Strategic Initiatives (PTGX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
